Condition
Recurrent Uti
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06332781Phase 4CompletedPrimary
Intravesical Gentamicin to Prevent Recurrent UTI
NCT06149676Early Phase 1RecruitingPrimary
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
NCT04096820Phase 2TerminatedPrimary
Uromune in Treating Recurrent Urinary Tract Infections in Women
NCT03644966Not ApplicableCompleted
Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03210038Not ApplicableCompleted
Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?
Showing all 5 trials